Skip to main content

Johannesburg, South Africa. Following a pre-Series, A round of USD 3 million, a new digital primary care platform will be formed in Africa. The founders are Webrock, the investment company that brought the number one digital health app in Brazil to South America, and Healthforce, a digital health company majority-owned by South Africas leading retail pharmacy chain Dis-Chem, will be taking the cutting-edge technology behind the second most downloaded doctor app in Europe, Doktor.se, to Africa. Doing so will provide the continent with a complete digital primary care platform. It will first be launched in South Africa, with a further continent-wide roll-out planned.

We spoke to Saul Kornik, CEO of Healthforce for the Business of Health, which is hosted on The Nielsen Network.

Watch the Business of Health video here:

Keep reading about the future of digital primary care in Africa

The platform, which makes use of a freemium model and innovative approaches to reduce data costs, offers on-demand and scheduled consultations with nurses, general practitioners, and mental health professionals. It will also provide ongoing wellness management. Its design ensures a fully integrated end-to-end healthcare system that allows for a holistic and comprehensive view of each patient across different cadres of healthcare workers, in order to allocate the most appropriate resource to meet the needs of the patient.

digital primary care in AfricaAdditionally, it will be incorporated into Healthforces network of 450 primary care clinics across South Africa where hands-on care will be provided if needed. The solution is set to reduce the cost of quality care while measurably improving health outcomes. It will help to reach patients in remote areas, and alleviate the pressure on the traditional medical support systems.

Currently, only 16% of South Africans[i], 9% of Nigerians[ii] and 1% of Ugandans[iii] for example have medical scheme cover since the costs remain out of reach for the majority of the African population.”

 While governments on the continent are attempting to make quality health services more accessible via national health insurance schemes, universal healthcare provision has not proven feasible seeing that there are people living in rural areas with little to no access to facilities, while others reside in urban areas and have these on their doorstep. But this new platform, to a large extent, ensures everyone can enjoy the same quality care from the same group of healthcare professionals, no matter where in Africa they are situated, as long as they have a cellphone and internet connection,” says Saul Kornik, CEO of Healthforce. 

Given the speed at which tele-health has grown over the past few years globally, coupled with our experience from successfully building Brazils largest digital health company, ViBe Saúde, there is a window of opportunity to transform access to healthcare on the African continent.”

With a large population and rapidly increasing smartphone and internet penetration, Africa is an obvious and attractive health tech market opportunity. Using data is infinitely cheaper than having to spend time and money traveling to and from clinics, not to mention paying for the clinic visit itself,” adds Joshin Raghubar, Partner at Webrock Ventures Africa. 

Covid-19 and digital primary care

The partners believe that it is the perfect time to launch such a platform due to the digital adoption that accompanied the COVID-19 crisis which has made South Africans more comfortable using tech to access services.

We are happy to be a part of unlocking the potential of telemedicine in Sub-Saharan Africa. Weve done this before with Webrock Ventures in Brazil and are proud to form a strategic partnership to repeat this success in a new market. Thanks to Healthforces impressive infrastructure, we believe that it will be possible to launch better and more accessible healthcare for everyone at a record pace.,” concludes Martin Lindman, Co-Founder & CEO at Doktor.se. 

The Newco aims to care for 75 million people in the next 10 years.

Watch more sessions on The Business of Health

Longevity Live has a series called The Business of Health, hosted on The Nielsen Network. The aim of the series is to provide insights into the business behind healthcare products and solutions. You can read and watch more interviews:

Longevity Live interviews the CEO of LifeQ Lawrence (Laurie) Olivier Biometrics.

Longevity Live interviews CMO of Frys Family Foods  Tammy Fry on the future of plant-based foods.

Longevity Live interviews the founder of Delic Corp Matt Stang on the therapeutic future of psychedelics for mental health.

 

Em Sloane

Em Sloane

I am an introverted nature lover, and long time contributor to LongevityLive.com. My role is to publish the information in a consumer friendly format, which we receive on the latest medical news, press releases and general information on the latest longevity related research findings.

Longevity Live is a digital publisher AND DOES NOT OFFER PERSONAL HEALTH OR MEDICAL ADVICE. IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY NUTRITION, DIET, EXERCISE, FITNESS, MEDICAL, OR WELLNESS PROGRAM.

This content, developed through collaboration with licensed medical professionals and external contributors, including text, graphics, images, and other material contained on the website, apps, newsletter, and products (“Content”), is general in nature and for informational purposes only and does not constitute medical advice; the Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.

Longevity Live makes no guarantees about the efficacy or safety of products or treatments described in any of our posts. Any information on supplements, related services and drug information contained in our posts are subject to change and are not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Longevity does not recommend or endorse any specific test, clinician, clinical care provider, product, procedure, opinion, service, or other information that may be mentioned on Longevity’s websites, apps, and Content.